General Information of Drug (ID: DMYNVLZ)

Drug Name
4-iodo-6-phenylpyrimidine Drug Info
Synonyms 41270-96-6; CHEMBL497802; AC-907/25004997; AC1LG8ZQ; SCHEMBL244108; CHEBI:91213; CTK7C3610; MolPort-003-800-888; ZINC331218; BDBM50265608; AKOS005266491; FCH1331127; 4-IPP, &gt
Cross-matching ID
PubChem CID
817368
ChEBI ID
CHEMBL91213
TTD Drug ID
D0W1WF

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
GnRH signaling pathway 1.91 4.01e-2 80/93 (86.02%) MAP2K1;RAF1;GNAS;...
Thyroid hormone signaling pathway 1.86 4.01e-2 112/121 (92.56%) RXRA;NOTCH3;MAP2K1;...
Sphingolipid signaling pathway 1.83 4.67e-2 106/119 (89.08%) MAP2K1;ABCC1;MAP3K5;...
Fc epsilon RI signaling pathway 1.80 4.45e-2 57/68 (83.82%) MAP2K1;PIK3CA;RAF1;...
Rap1 signaling pathway 1.76 4.96e-2 184/210 (87.62%) ID1;RALB;MET;...
VEGF signaling pathway 1.75 4.67e-2 50/59 (84.75%) MAP2K1;PIK3CA;RAF1;...
Yersinia infection 1.74 4.15e-2 120/137 (87.59%) MAP2K1;PIK3CA;ARPC1A;...
Melanogenesis 1.74 3.87e-2 74/101 (73.27%) WNT5A;MAP2K1;RAF1;...
Wnt signaling pathway 1.73 3.76e-2 124/166 (74.7%) WNT5A;DKK1;SFRP1;...
Spinocerebellar ataxia 1.73 3.56e-2 128/143 (89.51%) PSMB5;MAP3K5;PIK3CA;...
Hepatocellular carcinoma 1.71 3.70e-2 135/168 (80.36%) HMOX1;KEAP1;WNT5A;...
Estrogen signaling pathway 1.71 3.43e-2 119/137 (86.86%) HSPA1A;HSPA8;MAP2K1;...
Fc gamma R-mediated phagocytosis 1.70 3.65e-2 79/97 (81.44%) MAP2K1;PIK3CA;RAF1;...
Long-term depression 1.70 3.67e-2 55/60 (91.67%) MAP2K1;RAF1;GNAS;...
GnRH secretion 1.68 4.48e-2 60/64 (93.75%) MAP2K1;PIK3CA;RAF1;...
Shigellosis 1.68 4.30e-2 180/246 (73.17%) PIK3CA;ARPC1A;ROCK2;...
Endocrine and other factor-regulated calcium reabsorpti... 1.67 4.43e-2 49/53 (92.45%) GNAS;PRKCA;ATP1B1;...
Gap junction 1.67 4.21e-2 72/88 (81.82%) MAP2K1;RAF1;GNAS;...
Pathways in cancer 1.67 4.13e-2 474/531 (89.27%) HMOX1;KEAP1;COL4A5;...
Oocyte meiosis 1.66 4.07e-2 90/129 (69.77%) MAP2K1;YWHAH;ADCY7;...
Axon guidance 1.66 4.12e-2 151/182 (82.97%) WNT5A;NRP1;MET;...
Regulation of actin cytoskeleton 1.64 4.62e-2 185/218 (84.86%) MAP2K1;PIK3CA;RAF1;...
T cell receptor signaling pathway 1.62 4.93e-2 93/104 (89.42%) MAP2K1;PIK3CA;RAF1;...
Malaria -1.80 1.13e-2 44/50 (88%) GYPC;IL6;SELP;...
Glycine, serine and threonine metabolism -1.89 6.78e-3 31/40 (77.5%) ALDH7A1;GLDC;ALAS1;...
Steroid biosynthesis -2.13 0.00e+0 19/20 (95%) CYP27B1;TM7SF2;SQLE;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Ewing sarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-673 CVCL_0080 Homo sapiens 40uM 6H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 40uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CL-34 CVCL_1123 Homo sapiens 40uM 6H
HT-29 CVCL_0320 Homo sapiens 40uM 6H, 24H
LoVo CVCL_0399 Homo sapiens 40uM 6H
MDST8 CVCL_1400 Homo sapiens 40uM 6H
NCI-H508 CVCL_1561 Homo sapiens 40uM 6H
SNU-1040 CVCL_5001 Homo sapiens 40uM 6H
SNU-C4 CVCL_5008 Homo sapiens 40uM 6H
SNU-C5 CVCL_5009 Homo sapiens 40uM 6H
SW480 CVCL_0546 Homo sapiens 40uM 6H
SW620 CVCL_0547 Homo sapiens 40uM 6H
SW948 CVCL_0550 Homo sapiens 40uM 6H
Colorectal carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCT 116 CVCL_0291 Homo sapiens 40uM 6H
HT115 CVCL_1294 Homo sapiens 40uM 6H
RKO CVCL_0504 Homo sapiens 40uM 6H
Endometrium
Endometrial adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEC-108 CVCL_2926 Homo sapiens 40uM 6H
SNG-M CVCL_1707 Homo sapiens 40uM 6H
Endometrial carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
JHUEM-2 CVCL_1327 Homo sapiens 40uM 6H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 40uM 6H, 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 40uM 6H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 40uM 6H, 24H
DV-90 CVCL_1184 Homo sapiens 40uM 6H
SK-LU-1 CVCL_0624 Homo sapiens 40uM 6H
Lung adenosquamous carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H596 CVCL_1571 Homo sapiens 40uM 6H
Lung large cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
COR-L23 CVCL_1133 Homo sapiens 40uM 6H
T3M-10 CVCL_1729 Homo sapiens 40uM 6H
Lung squamous cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC15 CVCL_1253 Homo sapiens 40uM 6H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H1299 CVCL_0060 Homo sapiens 40uM 6H
HCC515 CVCL_5134 Homo sapiens 40uM 6H, 24H
NCI-H2073 CVCL_1523 Homo sapiens 40uM 6H
Small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H1694 CVCL_1495 Homo sapiens 40uM 6H
NCI-H1836 CVCL_1502 Homo sapiens 40uM 6H
Lymph node
Diffuse large B-cell lymphoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
WSU-DLCL2 CVCL_1787 Homo sapiens 40uM 6H
Ovary
Ovarian carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
EFO-27 CVCL_1194 Homo sapiens 40uM 6H
OV7 CVCL_1623 Homo sapiens 40uM 6H
Ovarian clear cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
RMG-I CVCL_1663 Homo sapiens 40uM 6H
Ovarian mucinous cystadenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
COV644 CVCL_2011 Homo sapiens 40uM 6H
RMUG-S CVCL_1666 Homo sapiens 40uM 6H
Ovarian undifferentiated carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
TYK-nu CVCL_1774 Homo sapiens 40uM 6H
Peripheral blood
Acute monocytic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
THP-1 CVCL_0006 Homo sapiens 40uM 6H
Acute myeloid leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NOMO-1 CVCL_1609 Homo sapiens 40uM 6H
PL-21 CVCL_2161 Homo sapiens 40uM 6H
SKM-1 CVCL_0010 Homo sapiens 40uM 6H
Pleural effusion
Histiocytic lymphoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-937 CVCL_0007 Homo sapiens 40uM 6H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 40uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 40uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 40uM 6H, 24H
SK-MEL-1 CVCL_0523 Homo sapiens 40uM 6H
SK-MEL-28 CVCL_0526 Homo sapiens 40uM 6H
Stomach
Gastric adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
AGS CVCL_0139 Homo sapiens 40uM 6H